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Purpose: The purpose of this study was to compare conventional diagnostic culture
(CDC) to 16S ribosomal RNA polymerase chain reaction (PCR) analysis for diagnosing
bacterial keratitis.
Methods: Samples collected from 100 consecutive patients presenting to the Royal
Liverpool University Hospital with bacterial keratitis were processed using CDC and 16S
PCR analysis.
Results:Theoverall detection rateusingbothmethodswas36%.Of these, 72.2% (26/36)
were detected by PCR and 63.9% (23/36) isolated by CDC (P = 0.62). Using a combina-
tion of both PCR and CDC increased the detection rate for pathogenic bacteria by 13%
compared to using CDC alone (P = 0.04). In CDC negative samples, 16S PCR identified
more pathogens than CDC in 16S PCR negative samples. Neither order of sample collec-
tion nor prior antimicrobial use affected the detection rate.
Conclusions:16S rRNAgenePCRperformed in addition toCDConcorneal samples from
patients with clinically suspected bacterial keratitis led to additional pathogen detec-
tion.
Translational Relevance: 16S rRNA gene PCR should be developed to become an
additional part of clinical service for patients with bacterial keratitis rather than used
in isolation.
Introduction
Bacterial keratitis is an ophthalmological emergency
that can lead to sight threatening complications, such
as corneal scarring, perforation, endophthalmitis, and
ultimately blindness.1 Improving outcomes depends on
rapidly identifying the causative microorganism.
Currently, the likely causativemicroorganism is only
isolated in 30% to 60% of cases using traditional
scraping methods and standard conventional diagnos-
tic culture (CDC), with results typically taking up to
3 days to become available to the clinician.1–3 This
may explain the reluctance of some ophthalmologists
to perform a corneal scrape to reach a microbiolog-
ical diagnosis. For example, McDonnell et al. found
that 49% of ophthalmologists treated corneal ulcers
empirically without attempting to identify the causative
organism.4 It is evident that improvements are required
in the detection and diagnosis of the causative bacteria
in cases of suspected bacterial keratitis.
These limitations have led to the identification of
more sensitive, rapid processing methods. The 16S
ribosomal DNA (16S RNA) gene is present in all
bacteria and consists of highly conserved regions
of nucleotide sequences, interspersed with 9 variable
regions that are genus or species specific. Broad range
polymerase chain reaction (PCR) primers that target
the conserved regions can amplify the variable regions,
which following sequencing and comparison to known
sequences in a stored database will identify the genus or
species of bacteria present in a sample.5–8 Broad range
bacterial PCR is especially advantageous in detect-
ing slow-growing bacteria or those bacteria that are
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traditionally difficult to cultivate.9–11 These PCR
techniques increase the potential to detect microorgan-
isms but converselymaymake it difficult for the treating
clinician to interpret which of the identified organisms
are causative.
In order to improve themicrobiological diagnosis of
a keratitis, different PCR techniques have been evalu-
ated, but with varying concordance between culture
and PCR results.12–19 These studies largely comprised
small numbers with different sampling techniques
(scrape versus swab) and none considered the effect of
sampling order on detection rates.
In this study, we compared the sensitivity of 16S
rRNA gene PCR to CDC for the diagnosis of bacte-
rial keratitis by controlling for the sampling technique,
order of sampling, and taking into account the detec-
tion of potential contaminating species.
Methods
Consecutive patients with clinically suspected bacte-
rial keratitis to the Royal Liverpool Hospital were
recruited at presentation until 100 patients had been
recruited. This sample size was determined on a differ-
ence between CDC and PCR of 20%, a type I error
(α) of 0.05, and a power of 0.8. Three corneal scrapes
were collected from the edge of the corneal ulcer
of each patient, as previously described.20 The first
scrape was smeared onto a glass slide for Gram stain-
ing, the second was placed into bovine heart infusion
(BHI) broth for CDC, and the third was transferred
into a sterile tube for 16S rRNA gene PCR analy-
sis. The order of sampling was: Gram stain, CDC,
and PCR for the first 50 samples and PCR, CDC,
and Gram stain for the subsequent 50 samples. All
included patients provided informed consent. The
study received prospective ethical approval from the
Northwest NHS Research Ethics Committee and was
conducted according to the ethical standards set out in
the 1964 Declaration of Helsinki, as revised in 2000.
Conventional Diagnostic Culture
Gram stain was carried out immediately on arrival
in the laboratory according to the British Society
for Antimicrobial Chemotherapy (BSAC) guidelines.21
The BHI bottles were vortexed for 5 to 10 seconds
and 10 μl inoculated onto blood, chocolate, and
Sabouraud’s dextrose agar plates. Agar plates and a
24-hour subculture of the BHI broth were examined
for evidence of bacterial growth after 24 hours and
48 hours of incubation. Sabouraud’s dextrose agar
plates were examined daily for 14 days for any growth.
All isolates were identified using matrix-assisted laser
desorption ionization time-of-flight mass spectrometry
(Bruker, Bremen, Germany).
16S rRNA Gene PCR
Four-hundred μl MagNA pure bacterial lysis buffer
(BLB; Roche Diagnostics Ltd., West Sussex, UK) was
added to the tubes containing corneal scrapes. The
tubes were vortexed for 1 minute and then sonicated
and centrifuged at 13,000 rpm for 3 minutes. Four-
hundred μl of BLB was transferred to a new tube,
heated at 95°C for 10 minutes, and DNAwas extracted
using the automated Roche Compact system (Roche
Diagnostics Ltd.).
PCR mix (20 μl volumes) was prepared using the
16S DNA free master mix kit (Molzym, Bremen,
Germany). Forward (AGAGTTTGATCMTG-
GCTCAG) and reverse (GGACTACCAGGGTATC-
TAATCCTGTT) primers, that amplify the first 5
variable regions of the 16S rRNA gene, were added
to the 2.5 times master mix, containing MolTaq 16S
and nuclease-free water, to give a final concentration
of 300 nM. PCR conditions were 95°C for 60 seconds,
followed by 35 cycles at 95°C for 10 seconds, 54°C
for 10 seconds, and 72°C for 50 seconds with a
final extension of 72°C for 5 minutes.22,23 Gel
electrophoresis was performed using a 2% agarose
gel containing ethidium bromide in 1 times tris-borate-
ethylenediaminetetraacetic (TBE) buffer for 25minutes
at 140 v. Any PCR amplicons were visualized under
UV light and then purified using an enzymatic
method (ExoSap-IT; Affymetrix, High Wycombe,
UK) according to the manufacturer’s instructions.
Cycle sequencing was performed by forward and
reverse priming using the Big Dye version 1.1
Terminator Reaction kit (Life Technologies, Paisley,
UK). Cycling conditions were: 95°C for 30 seconds,
followed by 25 cycles at 96°C for 10 seconds, 50°C
for 5 seconds, and 60°C for 4 minutes. Sequencing
was performed on a ABI3130 genetic analyzer (Life
Technologies) and sequence data analyzed using
SeqScape software. Consensus sequences of both
DNA strands were analyzed using the National Center
for Biotechnology Information (NCBI) Basic local
alignment search tool (BLAST) software available
at http://blast.ncbi.nlm.nih.gov/Blast.cgi. Sequences
from corneal scrapes were compared with those avail-
able in the GenBank database. Positive identifications
of bacteria to genus or species level were made accord-
ing to the Clinical and Laboratory Standards Institute
(CLSI) guidelines.24 The 16S PCR has been optimized
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Table 1. Positive and Negative Corneal Scrapes by
Conventional Diagnostic Culture and 16S rRNA Gene
Polymerase Chain Reaction
CDC +ve CDC -ve Total
16S PCR +ve 13 (56.5%) 13 (16.9%) 26
16S PCR -ve 10 (43.5%) 64 (83.1%) 74
Total 23 77 100
+ve = positive; –ve = negative; CDC = conventional
diagnostic; PCR = polymerase chain reaction methods.
to not amplify any bacterial DNA, which may be
inherent in reagents.22,23
Identification of Contaminant Species
Isolates were identified as positive or likely contam-
inant by the following definitions:
• CDC Positive: Clear organism/s isolated from
direct culture or significant organism isolated from
enrichment broth culture.
• CDC Contaminant: Present in enrichment broth
only and organism consistent with skin flora and
a not clearly significant organism (e.g., Coagu-
lase negative Staphylococci [CNS], Diphtheroid,
Alpha-hemolytic Streptococci, Bacillus sp. non-
cereus).
• 16S rRNA gene PCR Positive: ≥ 1+ band positive
and organism identified by sequencing, or ≥ 1+
electrophoresis gel band positive and positive on
repeat PCR.
• 16S rRNA gene PCR Contaminant: 1+ electrop-
horesis gel band positive only and negative on
repeat PCR testing.
Statistical Analysis
All data collected in the study were entered into
an electronic database via Microsoft Excel 2016 and
analyzed using SPSS (version 22). The χ2 was used as
indicated for the analysis of categorical variables.
Results
One hundred consecutive patients with clinically
suspected bacterial keratitis were included. The mean
age of the patients was 49 years (SD = 16.9). The
overall isolation rate was 36.0%. 72.2% (26/36) of
isolates were detected by 16S rRNA gene PCR and
63.9% (23/36) samples were detected by CDC (P =
0.622; see Tables 1–3). We demonstrated that using
a combination of both PCR and CDC detection
methods significantly increased the overall isolation
rate from 23.0% to 36.0% compared to using CDC
alone (P = 0.04).
Using the contamination definitions outlined
in the methods section, the overall rate of detec-
tion of contaminant species for both PCR and
CDC was 30.6% (11/36). 19.2% (5/26) of isolates
identified by 16S rRNA gene PCR were deemed
to be contaminant species compared to 30.4%
(7/23) of isolates identified by CDC (P = 0.363).
Possible contaminated samples are demonstrated in
Table 3.
The CDC and 16S rRNA gene PCR isolate
results for presumed pathogenic bacteria are presented
in Table 2. In 9 of 83 (10.8%) CDC negative samples,
presumed pathogenic bacteria were detected by 16S
PCR; Moraxella nonliquefaciens was isolated in 2
samples, P. aeruginosa in 2 samples, Acinetobacter sp.
in 1 sample and Methylobacterium sp. in 1 sample.
In two samples, mixed sequences were found and in
one sample the sequence was inconclusive. In 4 out
of 78 patients (5.1%) who were 16S PCR negative,
presumed pathogenic bacteria was detected by CDC;
Moraxella nonliquefaciens was isolated in 1 sample,
S. aureus isolated from the enrichment only in 2
samples, and 1 patient had CNS isolated from the agar
plate.
Of the 17 presumed pathogenic isolates detected by
CDC, 14 of 17 (82.4%) were identified to the species
level and 3 (17.6%) to the genus level. Of the 22
presumed pathogenic isolates detected by 16S rRNA
gene PCR, 11 of 22 (50.0%) were identified to the
species level, 3 (13.6%) to the genus level, and 9 (40.1%)
had inconclusive or mixed sequence results. Of the 13
samples that were positive by both 16S PCR and CDC,
there was genus concordance in 7 (53.8%); 5 samples
with Moraxella sp. and 2 samples with Pseudomonas
sp. Species concordance was demonstrated in 3 of
13 (23.1%) samples (Moraxella lacunata, Moraxella
catarrhalis, andP. aeruginosa).The 3 patients that were
found to have polymicrobial infection on CDC were all
found to have mixed nonidentifiable sequences on 16S
PCR.
Order of Sample Collection
The order of sample collection did not have any
effect on the rate of positive detection of microorgan-
isms by PCR; of the 22 PCR positive samples, 11 of
50 were collected as the first scrape and 11 of 50 as the
third, respectively (P = 1.0).
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Table 2. Samples Containing Pathogenic Microorganisms Identified by Conventional Diagnostic Culture and 16S
rRNA Gene Polymerase Chain Reaction
Sample CDC 16S PCR
1 Moraxella sp. Moraxella sp.
2 Moraxella sp. Moraxella nonliquefaciens
3 Moraxella lacunata Moraxella lacunata
4 Moraxella catarrhalis Moraxella nonliquefaciens
5 Moraxella catarrhalis Moraxella catarrhalis
6 Moraxella nonliquefaciens Nil
7 Nil Moraxella nonliquefaciens
8 Nil Moraxella nonliquefaciens
9 P. aeruginosa, α hemolytic Strep Mixed sequence
10 P. aeruginosa P. aeruginosa
11 Pseudomonas sp. P. aeruginosa
12 P. aeruginosa, Aspergillus flavus Mixed sequence
13 Nil P. aeruginosa
14 Nil P. aeruginosa
15 S. aureus (enrichment only) Mixed sequence
16 S. aureus (enrichment only) Nil
17 S. aureus (enrichment only) Nil
18 Enterobacter cloacae, α-hemolytic Strep Mixed sequence
19 Serratiamarcescens bacterial DNA
20 Nil Acinetobacter sp.
21 Nil Methylobacterium sp.
22 CNS +/− (plate) Nil
23 Nil Mixed sequence with Strep sp.
24 Nil Mixed sequence
25 Nil Bacterial DNA
CDC = conventional diagnostic culture; CNS = coagulase negative staphylococci; PCR = polymerase chain reaction.
Prior Antimicrobial Use
Thirty-four of 100 (34%) of the study samples
had received topical antimicrobial treatment prior to
sample collection: 21 chloramphenicol, 8 ciprofloxacin,
1 fucithalmic acid, 3 ciprofloxacin and teicoplanin, and
1 patient ciprofloxacin and fucithalmic acid. There was
no significant difference in the isolation rate detected
either by CDC or PCR between those patients who
had or had not received antimicrobial treatment prior
to sample collection, 7 of 34 (20.6%) and 19 of 66
(28.2%), respectively (P = 0.376). Of the nine patients
who had presumed pathogenic bacteria detected by
PCR only, two of nine (22%) had received antimicro-
bial treatment prior to sample collection. In both cases,
the antimicrobial used was chloramphenicol and the
organism identified by PCR was P. aeruginosa. Of the
four patients who had presumed pathogenic bacteria
detected by CDC only, two of four (50%) had antimi-
crobial treatment prior to sample collection. In both
cases, ciprofloxacin was used and the organism isolated
was S. aureus (from enrichment only). Of note, these
two samples were the only positive result from either
PCR or CDC among the patients who received prior
treatment with ciprofloxacin.
Discussion
In this study, we demonstrated that a combina-
tion of both CDC and 16S rRNA gene PCR signif-
icantly increased the overall isolation rate than CDC
alone. Although, in CDC negative samples, 16S PCR
yielded more results suggestive of potential pathogens
(M. nonliquefaciens and P. aeruginosa) than CDC in
16S PCR negative samples, comparatively more 16S
PCR positive samples were found to have inconclu-
sive results compared to CDC. We demonstrated that
problems of distinguishing infection from contami-
nation exist with both techniques. Neither order of
sample collection nor prior antimicrobial use was
demonstrated to affect the isolation rate with either
method.
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Table 3. Samples Containing Contaminating Microorganisms Identified by Conventional Diagnostic Culture and
16S rRNA Gene Polymerase Chain Reaction
Sample
PCR Sample
Collected CDC Contaminant PCR Band PCR Contaminant
Repeat PCR
Band
1 Third scrape CNS (enrichment only) NEG
2 Third scrape CNS (enrichment only) NEG
3 Third scrape CNS (enrichment only) NEG
4 Third scrape Mixed CNS (enrichment only) NEG
5 Third scrape Mixed CNS (from enrichment) NEG
6 First scrape CNS (enrichment only) NEG
7 Third scrape Bacillus sp. + Corynebacteriummastididis NEG
8 Third scrape No growth + Propionibacterium acnes NEG
9 Third scrape No growth + Acinetobacter sp. NEG
10 First scrape No growth + Bacterial DNA NEG
11 First scrape No growth + Bacterial DNA NEG
CDC = conventional diagnostic culture; CNS = Coagulase negative staphylococci; PCR = polymerase chain reaction;
NEG = negative; POS = positive.
As far as we are aware, this is the first prospec-
tive study to control for sampling methodology and
order and also identify possible contaminating organ-
isms in a large patient cohort. The absence of detecting
a difference between CDC and PCR may reflect that
the study was under powered given the actual CDC
and PCR rates, which were lower than expected, that
is, a post hoc power calculation is 14% as opposed to
the intended 20%. Despite these limitations, the results
are comparable to those reported from noncontrolled
studies by Kim et al.18 and Panda et al.19. Kim et al.18
compared CDC from corneal scrapings to 16S PCR
from corneal swabs and demonstrated similar CDC
and 16S positive isolation rates to our study. Panda
et al.19 comparedCDC from samples obtained from the
cornea via a cotton tippled applicator to 16S PCR from
corneal scrapings in 122 bacterial keratitis patients,
reporting 43.5% CDC positive and 45.9% 16S PCR
positive. These rates are higher than the isolation rates
demonstrated within this study and are likely related to
the increased severity of infection seen on presentation
compared to a typical UK population.25,26 Compara-
tively much smaller studies carried out byKnox et al.,13
Ameen et al.,14 Eleinen et al.,15 Itahashi et al.,16 and
Rudolph et al.17 demonstrated positive isolation rates
for CDC varying between 25% and 57.5% and for PCR
45.5% and 100%.
In infections other than ophthalmic infections, 16S
PCR and CDC have a concordance of approximately
90.6%.27,28 High concordance rates of 70% to 100%
are also seen in endophthalmitis.29,30 This is in contrast
to bacterial keratitis, where concordance rates are
typically much lower, as demonstrated in our study.12,18
Lower concordance rates in bacterial keratitis may
be attributable to the detection of either colonizing
or contaminating microorganisms by CDC/PCR. This
is a difficult factor to assess with any certainty. For
example, in our study, the one case in whichMoraxella
nonliquefaciens was isolated using CDC but not with
PCR and the two cases in which S. aureus (an accepted
pathogen) were isolated only in enrichment culture but
notwith PCRmay represent failure by PCRor contam-
ination in CDC.
PCR is capable of 106 to 107-fold amplifica-
tion of a single copy of template DNA, making
minor contamination of the PCR mixture with exoge-
nous DNA a problem.31 This is highlighted by Kim
et al.18 who demonstrated high 16S PCR false positive
rates for apparently nonpathogenic organisms with
control “air” swabs and by Corless et al.32 who
demonstrated amplification of 16S rRNA sequences
when no exogeneous DNA had been added to a
negative control. In our study, in the cases where CDC
was negative but Methylobacterium or unidentifiable
sequences of bacterium DNA were identified by PCR,
this could represent a similar contamination process
either with environmental or commensal ocular surface
bacteria or bacteria introduced during sample process-
ing. PCR reagent treatment with UV irradiation, 8-
methoxypsoralen activity facilitated byUV, andDNase
alone and in combination with restriction digestion
have all been demonstrated to reduce PCR sensitiv-
ity and could improve specificity and interpretation of
PCR results.32
Lower concordance rates between CDC and PCR
in bacterial keratitis could also be due to processing
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biases. CDC results are likely to be biased to more
fast-growingmicroorganisms, which can be easily culti-
vated on a standard media. In our study, the PCR
negative but CDC positive results may have resulted
from difficulties in breaking the cell walls of Gram-
positive organisms during the DNA extraction process.
Using amore effectivemethod, such chemical lysis with
proteinase K or mechanical disruption, may result in
more reliable PCR detection.
Polymicrobial keratitis has an 2% to 8% incidence
rate in the literature and is associated with larger
corneal infiltrate size and greater mean duration for
resolution of infection.31,32 In our study, all three
samples with mixed growth on CDC had an unidenti-
fied mixed sequence on PCR. 16S rRNA gene sequenc-
ing using bulk PCR products cannot be applied to
polymicrobial bacterial specimens as the presence of
multiple templates results in superimposed reads that
are mostly uninterpretable.35
Prior antimicrobial use had no effect on the positiv-
ity of samples from 16s rRNA gene PCR in our study.
This was unexpected because PCR can amplify dead
bacteria, which are unable to grow for bacterial culture,
and is in contrast to several studies who found that
antibiotics before specimen collection was a significant
factor in reducing culture positivity.12,19 The compara-
tively small numbers of patients who had used topical
antimicrobial therapy in our study may account for the
fact that we saw this lack of effect.
For the purposes of this study, only cases of
suspected bacterial keratitis cases were investigated
using CDC and PCR. BHI bottles were, however,
inoculated onto Sabouraud’s dextrose agar plates for
fundal growth. Internal transcribed spacer (ITS), 28S
rRNA, and 18S rRNA PCR have all been demon-
strated to increase fungal detection rate in culture-
negative cases and fungal PCR would be a useful
adjunct to culture.36–38 Multiplex real-time PCR assays
are also being increasingly used for the diagnosis
of viral keratitis.39 Until newer techniques, such as
shotgun metagenomics, become more clinically inter-
pretable and cost effective, a PCR assay that combines
broad range primers for bacterial, fungal, and viral
detection is an interesting avenue that would allow
rapid detection in keratitis cases where the diagnosis is
not clear or when the keratitis is polymicrobial.
In conclusion, although we did not find 16S rRNA
gene PCR to have a significantly higher sensitivity for
detecting the presence of bacteria in corneal scrape
samples compared to CDC, additional presumed
pathogenic bacteria were identified in CDC negative
samples. PCR offers advantages over culture of rapid
analysis and the ability to detect organisms from very
low starting material, however, contamination and the
fact that PCR does not provide antimicrobial suscep-
tibility data means that it should still be continued to
be used as an adjunct technique to CDC in diagnosing
bacterial keratitis.
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